Stroke

This channel includes news and new technology innovations for stroke. It includes both diagnosis and treatment of stroke, stroke imaging, pharmaceuticals and interventional stroke technologies. Stroke comes in two forms, which have different therapies.

1. Ischemic stoke is a blockage of an artery in the brain, preventing blood flow and is offen referred to as a "brain attack" because it is a similar casue as a heart attack. This type of stroke is often treated with anti-coagulants, including use of tissue plasminogen activator (tPA). Interventional mechanical thrombectomy can also be used to remove the clot.

2. Hemorrhagic stroke is caused when there is bleeding due to a ruptured blood vessel in the brain caused by a brain aneurysm burst or a weakened blood vessels. These strokes are less common, but exact diagnosis is important, because use of tPA in these patients can have catastrophic consequences. Treatments include interventional embolization and surgical clipping of target vessels. 

InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid | November 18, 2016
November 18, 2016 — InspireMD Inc. announced in mid-October the online publication of positive clinical data in a new...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems | November 14, 2016
November 14, 2016 — Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower...
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders | November 02, 2016
November 2, 2016 — St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First...
St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch
Technology | Structural Heart Occluders | November 02, 2016
November 2, 2016 — St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and...
SentreHeart, Lariat Suture Delivery Device, financing round, aMAZE Trial
News | Left Atrial Appendage (LAA) Occluders | October 20, 2016
October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of...
recall, alligator retrieval device, X-Celerator hydrophilic guidewire, UltraFlow flow directed micro catheters, Marathon flow directed micro catheters
News | Cath Lab | October 18, 2016
October 18, 2016 — Medtronic plc announced last week that it has notified customers of a voluntary recall of certain...
transcarotid artery revascularization, TCAR Surveillance Project, Society for Vascular Surgery Patient Safety Organization, SVS PSO,
News | Stents Carotid | October 13, 2016
October 13, 2016 — A surveillance project to evaluate the safety and effectiveness of transcarotid artery...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices | September 28, 2016
September 28, 2016 — Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s...
PFO closure, patent foramen ovale, AAN recommendation, American Academy of Neurology, stroke patients
News | Structural Heart Occluders | August 08, 2016
August 8, 2016 — Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based...
Penumbra System, ACE68 Reperfusion Catheter, thrombectomy device, SNIS 2016, acute ischemic stroke patients
Technology | Thrombectomy Devices | July 27, 2016
July 27, 2016 — Penumbra Inc. announced U.S. commercial availability of its latest thrombectomy device, the ACE68...
Million Hearts Cardiovascular Disease Risk Reduction Model, CMS, reduce heart attacks and strokes, participants
News | Patient Engagement | July 22, 2016
July 22, 2016 — The Centers for Medicare & Medicaid Services (CMS) recently announced 516 awardees in 47 states,...
DEFUSE-2 study, MRI, brain bleeding risk, post-stroke treatment, NIH

This image combines pre- and post-treatment scans from the same patient. Analysis of the two scans revealed that the area and size of post-treatment bleeding corresponded to blood-brain barrier disruption (shown in green, yellow and red) prior to therapy. Image courtesy of Richard Leigh, NINDS.

News | Stroke | June 29, 2016
June 29, 2016 — In a study of stroke patients, investigators confirmed through magnetic resonance imaging (MRI) brain...
atrial fibrillation, stroke risk, aspirin vs blood thinners, JACC study
News | Antiplatelet and Anticoagulation Therapies | June 24, 2016
June 24, 2016 — More than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated...
hemmorhagic stroke, blood pressure management, ATACH II trial, NINDS

Brain scan showing damage caused by bleeding during a hemorrhagic stroke. Image courtesy of Adnan I Qureshi, M.D., University of Minnesota.

News | Stroke | June 09, 2016
June 9, 2016 — An international stroke study found that standard and intensive blood pressure treatments were equally...
female patients, atrial fibrillation, blood thinning therapy, AFDST, decision support tool, Cincinnati
News | Antiplatelet and Anticoagulation Therapies | June 02, 2016
June 2, 2016 — Female atrial fibrillation patients are less likely than their male counterparts to receive blood...